This paper critically analyzes the implications of the 2022 National Association of Statutory Health Insurance Funds Financial Stabilization Act (GKV-FinStG) on pharmaceutical dynamics in Germany.
This paper critically analyzes the implications of the 2022 National Association of Statutory Health Insurance Funds Financial Stabilization Act (GKV-FinStG) on pharmaceutical dynamics in Germany.